Article
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes.
Leukemia research - 1 Dec 2015
Badar Talha, Patel Keyur P, Thompson Philip A, DiNardo Courtney, Takahashi Koichi, Cabrero Monica, Borthakur Gautam, Cortes Jorge, Konopleva Marina, Kadia Tapan, Bohannan Zach, Pierce Sherry, Jabbour Elias J, Ravandi Farhad, Daver Naval, Luthra Raja, Kantarjian Hagop, Garcia-Manero Guillermo
Abstract excerpt
BACKGROUND: The molecular events that drive the transformation from myelodysplastic syndromes (MDS) to acute myeloid leukemia (AML) have yet to be fully characterized. We hypothesized that detection of these mutations at the time of transformation from MDS to AML may lead to poorer outcomes. METHODS: We analyzed 102 MDS patients who were admitted to our institution between 2004 and 2013, had wild-type (wt)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
